CONSILIENT HEALTH LAUNCHES GHRYVELIN™ (macimorelin), A NOVEL ORAL DIAGNOSTIC TEST FOR ADULT GROWTH HORMONE DEFICIENCY
FOR UK/EUROPEAN MEDICAL AND TRADE MEDIA ONLY DUBLIN, IRELAND, May 26, 2022 /EINPresswire.com/ -- Consilient Health has today announced the launch of Ghryvelin™ (macimorelin), the first oral test licensed for diagnosing Growth Hormone Deficiency (AGHD) …